FDG PET/CT in oncology: “raising the bar”
Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[18 F]-fluoro-2-deoxy- d- glucose (FDG) has revolutionized oncological imaging in recent years and now has a firmly established role in a variety of tumour types. There have been simultaneous step-wise advances in scanner te...
Gespeichert in:
| Veröffentlicht in: | Clinical radiology 2010-07, Vol.65 (7), p.522-535 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 535 |
|---|---|
| container_issue | 7 |
| container_start_page | 522 |
| container_title | Clinical radiology |
| container_volume | 65 |
| creator | Patel, C.N Goldstone, A.R Chowdhury, F.U Scarsbrook, A.F |
| description | Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[18 F]-fluoro-2-deoxy- d- glucose (FDG) has revolutionized oncological imaging in recent years and now has a firmly established role in a variety of tumour types. There have been simultaneous step-wise advances in scanner technology, which are yet to be exploited to their full potential in clinical practice. This article will review these technological developments and explore how refinements in imaging protocols can further improve the accuracy and efficacy of PET/CT in oncology. The promises, and limitations, of emerging oncological applications of FDG PET/CT in radiotherapy planning and therapy response assessment will be explored. Potential future developments, including the use of FDG PET probes in oncological surgery, advanced data analysis techniques, and the prospect of integrated PET/magnetic resonance imaging (PET/MRI) will be highlighted. |
| doi_str_mv | 10.1016/j.crad.2010.01.003 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733336324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009926010000310</els_id><sourcerecordid>733336324</sourcerecordid><originalsourceid>FETCH-LOGICAL-c476t-7a005a7961d4e3824e6a32ab8ac13334583e20ea9dc115d21ec8b87728f2f0e53</originalsourceid><addsrcrecordid>eNp9kc1KAzEUhYMotlZfwIXMztW0N8n8ighS2yoIClZwFzKZOzV1OlOTVuiuD6Iv1ycxQ6sLF67uD-ccuN8l5JRClwKNetOuMjLvMnALoF0AvkfalEehz1j6sk_aAJD6KYugRY6snTZjwIJD0mIQBjQKWZv4w5uR9zgY9_pjT1deXam6rCerC2-z_jRSW11NvMUrepk0m_XXMTkoZGnxZFc75Hk4GPdv_fuH0V3_-t5XQRwt_FgChDJOI5oHyBMWYCQ5k1kiFeWcB2HCkQHKNFeUhjmjqJIsiWOWFKwADHmHnG9z56Z-X6JdiJm2CstSVlgvrYhdCo84C5ySbZXK1NYaLMTc6Jk0K0FBNJTEVDSURENJABWOkjOd7eKX2QzzX8sPFie43ArQHfmh0QirNFYKc21QLURe6__zr_7YVakrrWT5hiu003ppKodPUGGZAPHUPKZ5E3UNcAr8Gyoki1M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733336324</pqid></control><display><type>article</type><title>FDG PET/CT in oncology: “raising the bar”</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Patel, C.N ; Goldstone, A.R ; Chowdhury, F.U ; Scarsbrook, A.F</creator><creatorcontrib>Patel, C.N ; Goldstone, A.R ; Chowdhury, F.U ; Scarsbrook, A.F</creatorcontrib><description>Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[18 F]-fluoro-2-deoxy- d- glucose (FDG) has revolutionized oncological imaging in recent years and now has a firmly established role in a variety of tumour types. There have been simultaneous step-wise advances in scanner technology, which are yet to be exploited to their full potential in clinical practice. This article will review these technological developments and explore how refinements in imaging protocols can further improve the accuracy and efficacy of PET/CT in oncology. The promises, and limitations, of emerging oncological applications of FDG PET/CT in radiotherapy planning and therapy response assessment will be explored. Potential future developments, including the use of FDG PET probes in oncological surgery, advanced data analysis techniques, and the prospect of integrated PET/magnetic resonance imaging (PET/MRI) will be highlighted.</description><identifier>ISSN: 0009-9260</identifier><identifier>EISSN: 1365-229X</identifier><identifier>DOI: 10.1016/j.crad.2010.01.003</identifier><identifier>PMID: 20541652</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Fluorodeoxyglucose F18 ; Humans ; Neoplasm Staging ; Neoplasms - diagnostic imaging ; Neoplasms - pathology ; Neoplasms - radiotherapy ; Positron-Emission Tomography - standards ; Positron-Emission Tomography - trends ; Practice Guidelines as Topic ; Radiology ; Radiopharmaceuticals ; Tomography, X-Ray Computed - standards ; Tomography, X-Ray Computed - trends ; United Kingdom</subject><ispartof>Clinical radiology, 2010-07, Vol.65 (7), p.522-535</ispartof><rights>The Royal College of Radiologists</rights><rights>2010 The Royal College of Radiologists</rights><rights>Copyright 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c476t-7a005a7961d4e3824e6a32ab8ac13334583e20ea9dc115d21ec8b87728f2f0e53</citedby><cites>FETCH-LOGICAL-c476t-7a005a7961d4e3824e6a32ab8ac13334583e20ea9dc115d21ec8b87728f2f0e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.crad.2010.01.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20541652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patel, C.N</creatorcontrib><creatorcontrib>Goldstone, A.R</creatorcontrib><creatorcontrib>Chowdhury, F.U</creatorcontrib><creatorcontrib>Scarsbrook, A.F</creatorcontrib><title>FDG PET/CT in oncology: “raising the bar”</title><title>Clinical radiology</title><addtitle>Clin Radiol</addtitle><description>Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[18 F]-fluoro-2-deoxy- d- glucose (FDG) has revolutionized oncological imaging in recent years and now has a firmly established role in a variety of tumour types. There have been simultaneous step-wise advances in scanner technology, which are yet to be exploited to their full potential in clinical practice. This article will review these technological developments and explore how refinements in imaging protocols can further improve the accuracy and efficacy of PET/CT in oncology. The promises, and limitations, of emerging oncological applications of FDG PET/CT in radiotherapy planning and therapy response assessment will be explored. Potential future developments, including the use of FDG PET probes in oncological surgery, advanced data analysis techniques, and the prospect of integrated PET/magnetic resonance imaging (PET/MRI) will be highlighted.</description><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Neoplasm Staging</subject><subject>Neoplasms - diagnostic imaging</subject><subject>Neoplasms - pathology</subject><subject>Neoplasms - radiotherapy</subject><subject>Positron-Emission Tomography - standards</subject><subject>Positron-Emission Tomography - trends</subject><subject>Practice Guidelines as Topic</subject><subject>Radiology</subject><subject>Radiopharmaceuticals</subject><subject>Tomography, X-Ray Computed - standards</subject><subject>Tomography, X-Ray Computed - trends</subject><subject>United Kingdom</subject><issn>0009-9260</issn><issn>1365-229X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1KAzEUhYMotlZfwIXMztW0N8n8ighS2yoIClZwFzKZOzV1OlOTVuiuD6Iv1ycxQ6sLF67uD-ccuN8l5JRClwKNetOuMjLvMnALoF0AvkfalEehz1j6sk_aAJD6KYugRY6snTZjwIJD0mIQBjQKWZv4w5uR9zgY9_pjT1deXam6rCerC2-z_jRSW11NvMUrepk0m_XXMTkoZGnxZFc75Hk4GPdv_fuH0V3_-t5XQRwt_FgChDJOI5oHyBMWYCQ5k1kiFeWcB2HCkQHKNFeUhjmjqJIsiWOWFKwADHmHnG9z56Z-X6JdiJm2CstSVlgvrYhdCo84C5ySbZXK1NYaLMTc6Jk0K0FBNJTEVDSURENJABWOkjOd7eKX2QzzX8sPFie43ArQHfmh0QirNFYKc21QLURe6__zr_7YVakrrWT5hiu003ppKodPUGGZAPHUPKZ5E3UNcAr8Gyoki1M</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Patel, C.N</creator><creator>Goldstone, A.R</creator><creator>Chowdhury, F.U</creator><creator>Scarsbrook, A.F</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100701</creationdate><title>FDG PET/CT in oncology: “raising the bar”</title><author>Patel, C.N ; Goldstone, A.R ; Chowdhury, F.U ; Scarsbrook, A.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c476t-7a005a7961d4e3824e6a32ab8ac13334583e20ea9dc115d21ec8b87728f2f0e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Neoplasm Staging</topic><topic>Neoplasms - diagnostic imaging</topic><topic>Neoplasms - pathology</topic><topic>Neoplasms - radiotherapy</topic><topic>Positron-Emission Tomography - standards</topic><topic>Positron-Emission Tomography - trends</topic><topic>Practice Guidelines as Topic</topic><topic>Radiology</topic><topic>Radiopharmaceuticals</topic><topic>Tomography, X-Ray Computed - standards</topic><topic>Tomography, X-Ray Computed - trends</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patel, C.N</creatorcontrib><creatorcontrib>Goldstone, A.R</creatorcontrib><creatorcontrib>Chowdhury, F.U</creatorcontrib><creatorcontrib>Scarsbrook, A.F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patel, C.N</au><au>Goldstone, A.R</au><au>Chowdhury, F.U</au><au>Scarsbrook, A.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FDG PET/CT in oncology: “raising the bar”</atitle><jtitle>Clinical radiology</jtitle><addtitle>Clin Radiol</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>65</volume><issue>7</issue><spage>522</spage><epage>535</epage><pages>522-535</pages><issn>0009-9260</issn><eissn>1365-229X</eissn><abstract>Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[18 F]-fluoro-2-deoxy- d- glucose (FDG) has revolutionized oncological imaging in recent years and now has a firmly established role in a variety of tumour types. There have been simultaneous step-wise advances in scanner technology, which are yet to be exploited to their full potential in clinical practice. This article will review these technological developments and explore how refinements in imaging protocols can further improve the accuracy and efficacy of PET/CT in oncology. The promises, and limitations, of emerging oncological applications of FDG PET/CT in radiotherapy planning and therapy response assessment will be explored. Potential future developments, including the use of FDG PET probes in oncological surgery, advanced data analysis techniques, and the prospect of integrated PET/magnetic resonance imaging (PET/MRI) will be highlighted.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>20541652</pmid><doi>10.1016/j.crad.2010.01.003</doi><tpages>14</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0009-9260 |
| ispartof | Clinical radiology, 2010-07, Vol.65 (7), p.522-535 |
| issn | 0009-9260 1365-229X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733336324 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Fluorodeoxyglucose F18 Humans Neoplasm Staging Neoplasms - diagnostic imaging Neoplasms - pathology Neoplasms - radiotherapy Positron-Emission Tomography - standards Positron-Emission Tomography - trends Practice Guidelines as Topic Radiology Radiopharmaceuticals Tomography, X-Ray Computed - standards Tomography, X-Ray Computed - trends United Kingdom |
| title | FDG PET/CT in oncology: “raising the bar” |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A18%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FDG%20PET/CT%20in%20oncology:%20%E2%80%9Craising%20the%20bar%E2%80%9D&rft.jtitle=Clinical%20radiology&rft.au=Patel,%20C.N&rft.date=2010-07-01&rft.volume=65&rft.issue=7&rft.spage=522&rft.epage=535&rft.pages=522-535&rft.issn=0009-9260&rft.eissn=1365-229X&rft_id=info:doi/10.1016/j.crad.2010.01.003&rft_dat=%3Cproquest_cross%3E733336324%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733336324&rft_id=info:pmid/20541652&rft_els_id=S0009926010000310&rfr_iscdi=true |